We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Meir Schechter

Meir Schechter MD, PhD

Faculty of Medicine, Hebrew University of Jerusalem, Israel; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel

Meir Schechter is an MD/PhD graduate of the faculty of medicine, Hebrew University of Jerusalem, Israel. He completed his PhD under the mentorship of Prof. Ronit Sharon at the department of biochemistry and molecular biology, investigating molecular mechanisms underlying the pathophysiology of Parkinson’s diseases. His work focused on α-Synuclein interactions with brain lipids, with relevance to neuroplasticity and neurodegeneration.

Meir is now a post-doc fellow at the Diabetes Clinical Research Center at Hadassah Medical Center, Israel, led by Dr. Ofri Mosenzon. His research interests include diabetes and its complications, with specific interests in diabetic kidney disease.

Disclosures

Dr. Schechter has no relevant disclosures.